Literature DB >> 9459164

Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study.

J Iscovich1, O Paltiel, E Azizi, A Kuten, A Gat, B Lifzchitz-Mercer, A Zlotogorski, A Polliack.   

Abstract

The incidence rate of cutaneous lymphomas (CL) [including mycosis fungoides (MF) and non-mycosis fungoides (non-MF)] for the period 1985-93 in Israel was determined using data from the population-based Cancer Registry supplemented by a field survey that covered approximately 80% of lymphoma cases. After the field survey, corrected rates were 49% and 24% higher for MF and non-MF respectively (37% for CL overall). The age-adjusted incidence rates per 100,000 were 1.18 and 0.63 for Jewish men and women respectively. MF rates (0.77 in men and 0.35 in women) were higher than non-MF (0.41 and 0.28 respectively). Rates of CL were significantly lower in non-Jews. There were no significant differences in incidence among Jewish ethnic subgroups. However, the lack of variability in the incidence of these neoplasms among subpopulations is in contrast with findings for cutaneous malignant melanoma; the observed high rates of CL could, nonetheless, be consistent with the sunlight exposure hypothesis, operating perhaps through a different mechanism.

Entities:  

Mesh:

Year:  1998        PMID: 9459164      PMCID: PMC2151272          DOI: 10.1038/bjc.1998.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population.

Authors:  T Y Chuang; W P Su; S A Muller
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

2.  Risk of second malignancy after cutaneous T-cell lymphoma.

Authors:  A F Kantor; R E Curtis; E C Vonderheid; E J van Scott; J F Fraumeni
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

3.  A case-control study of possible causative factors in mycosis fungoides.

Authors:  E Tuyp; A Burgoyne; T Aitchison; R MacKie
Journal:  Arch Dermatol       Date:  1987-02

4.  Report of the Dutch Mycosis Fungoides Study Group [proceedings].

Authors:  L Hamminga; W A van Vloten
Journal:  Br J Dermatol       Date:  1980-04       Impact factor: 9.302

5.  The effect of diagnostic review on the estimated incidence of lymphatic and hematopoietic neoplasms in Western Australia.

Authors:  L E Dougan; M L Matthews; B K Armstrong
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

6.  Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology.

Authors:  M A Weinstock; J W Horm
Journal:  JAMA       Date:  1988-07-01       Impact factor: 56.272

7.  Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.

Authors:  R J Biggar; J Horm; J F Fraumeni; M H Greene; J J Goedert
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

8.  Mycosis fungoides in Norway 1960-80. A retrospective study.

Authors:  N McFadden; A Nyfors; G Tanum; A Granholt; P Helme; G Kavli
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1983

Review 9.  Effects of ultraviolet radiation on the immune system in humans.

Authors:  W L Morison
Journal:  Photochem Photobiol       Date:  1989-10       Impact factor: 3.421

10.  Mycosis fungoides in relation to environmental exposures and immune response: a case-control study.

Authors:  A S Whittemore; E A Holly; I M Lee; E A Abel; R M Adams; B J Nickoloff; L Bley; J M Peters; C Gibney
Journal:  J Natl Cancer Inst       Date:  1989-10-18       Impact factor: 13.506

View more
  2 in total

1.  Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.

Authors:  M A Weinstock; B Gardstein
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  Occupational ultraviolet exposure and risk of non-Hodgkin's lymphomas: a meta-analysis.

Authors:  Demin Lu; Fei Xu; Kaiming Hu; Li Yin; Huijie Duan; Jiaojiao Zhang; SuZhan Zhang
Journal:  Oncotarget       Date:  2017-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.